Healthcare and digital health investments soar to record $28.8 billion in 2025

Investment in healthcare and digital health surged in 2025, with major deals reshaping the industry. Billions flowed into women’s health, fertility, and AI-driven treatments, while funding for startups hit record highs. The year also saw large acquisitions and public offerings, signalling strong confidence in the sector’s growth. Global digital health funding climbed to $28.8 billion in 2025, a 9% rise from the previous year. The U.S. alone accounted for $14.2 billion, marking a 35% jump as startups attracted more capital. Europe led regional growth with a 15% increase, outpacing other markets.

Women’s health emerged as a standout sector. US Fertility partnered with L Catterton and Amulet Capital to push for standardised, tech-driven fertility services. Visana Health secured $24 million in Series A funding to grow its virtual-first women’s clinic, while Midi Health raised $50 million for menopause care—one of the largest rounds in the field. Oura, the wearable tech company, closed over $900 million at an $11 billion valuation, expanding into reproductive health tracking. Big-ticket acquisitions also dominated. KKR bought Karo Healthcare for $2.5 billion, adding intimate care and women’s health brands to its portfolio. Blackstone and TPG took Hologic private in an $18.3 billion deal, one of the largest healthcare buyouts of the year. Meanwhile, Caris Life Sciences raised $494 million in its IPO, bringing AI-powered genomics to institutional investors. In chronic disease and obesity care, Omada Health raised $150 million through a public offering to scale its diabetes and weight management programs. Knownwell secured $25 million, led by CVS Ventures, to expand its hybrid obesity treatment model. Tubulis also drew $361 million in Series C funding to advance ovarian cancer therapies. Tech giants made moves too. OpenAI acquired Torch for $100 million, aiming to integrate health record analysis into its new ChatGPT Health feature. Research from AOA Dx highlighted women’s health as a proven exit market, with $100 billion in M&A and IPO activity since 2000. Progyny, a women’s health specialist, reported a 16.5% revenue increase in Q1 2025, reaching $324 million.

The surge in funding and high-value deals confirms healthcare’s rapid transformation. Digital health, women’s health, and AI-driven solutions are now key investment areas. With record-breaking rounds and acquisitions, the sector is set for further expansion in the coming years.